Join to View Full Profile
4100 John R StDetroit, MI 48201
Phone+1 313-576-8780
Fax+1 313-576-8661
Dr. Modi is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Detroit Medical Center/Wayne State UniversityFellowship, Hematology and Medical Oncology, 2016 - 2019- Detroit Medical Center/Wayne State UniversityResidency, Internal Medicine, 2012 - 2015
Wayne State University School of MedicineClass of 2015
Certifications & Licensure
GA State Medical License 2026 - 2028
MI State Medical License 2012 - 2028
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
HematologyHematology- Medical OncologyMedical Oncology
Awards, Honors, & Recognition
- ASH Abstract Achievement Award American Society of Hematology, 2017
Publications & Presentations
PubMed
- 1 citationsHematopoietic Cell Transplant Access and Patient Diversity.Rachel Cusatis, Jianqun Kou, Caitrin Bupp, Deborah Mattila, Ramzi Abboud
JAMA Network Open. 2026-05-01 - Comparison of Outcomes With Novel Versus Traditional Chemotherapy Regimens for Relapsed and Refractory Classical Hodgkin Lymphoma.Daniel Ermann, Victoria Vardell, Erin Zacholski, Amanda Fegley, Dipenkumar Modi
Clinical Lymphoma, Myeloma & Leukemia. 2026-05-01 - Mosunetuzumab plus polatuzumab vedotin in relapsed/refractory MCL after BTK inhibitor therapy: a phase 2 study.Lihua E Budde, Manali Kamdar, Sarit E Assouline, Julio C Chavez, Nilanjan Ghosh
Blood. 2026-04-21
Journal Articles
- Liver Graft-Versus-Host Disease is associated with poor survival among allogeneic hematopoietic stem cell transplant recipients.Modi D, Ye JC, Surapaneni M, Singh V, Chen W, Jang H, Deol A, Ayash L, Alavi A, Ratanatharathorn V, Uberti JP, American Journal of Hematology, 7/10/2019
Abstracts/Posters
- Use of Thymoglobulin with Lower Dose of Busulfan Results in Less Acute Gvhd Following Unrelated Donor Allogeneic Stem Cell Transplantation for AML without Affecting Re...Dipenkumar Modi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Lectures
- Absolute Lymphocyte Count (ALC) Less Than 100 Predicts Adverse Transplant Outcomes with Rabbit Thymoglobulin in Patients Undergoing Matched Unrelated Allogeneic Hemato...61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Maintenance Therapy after Second Autologous Stem Cell Transplant in Multiple Myeloma Improves Overall Survival61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Press Mentions
Grant to Barbara Ann Karmanos Cancer Institute Funds Study to Identify DLBCL Patients Likely to Relapse Post Autologous Stem Cell TransplantationApril 6th, 2021- Karmanos Cancer Center Gets $320,000 Federal Grant for Lymphoma ResearchApril 5th, 2021
- Karmanos Cancer Institute Receives a $325,372 Grant from U CAN-CER VIVE FoundationMarch 29th, 2021
Professional Memberships
- Member
- Member
Other Languages
- Hindi, Gujarati
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
